Liu, Dan, Zhen, Changlin, He, Xiuzhen, chen, wansong, Pan, Juan, Yin, Mengying, Zhong, Mengru, Zhang, Hongyan, Huang, Xiaohuan, Zhang, Yonghui. (1403). Naringin alleviates gefitinib-induced hepatotoxicity through anti-oxidation, inhibition of apoptosis, and autophagy. , 27(10), 1309-1316. doi: 10.22038/ijbms.2024.76852.16623
Dan Liu; Changlin Zhen; Xiuzhen He; wansong chen; Juan Pan; Mengying Yin; Mengru Zhong; Hongyan Zhang; Xiaohuan Huang; Yonghui Zhang. "Naringin alleviates gefitinib-induced hepatotoxicity through anti-oxidation, inhibition of apoptosis, and autophagy". , 27, 10, 1403, 1309-1316. doi: 10.22038/ijbms.2024.76852.16623
Liu, Dan, Zhen, Changlin, He, Xiuzhen, chen, wansong, Pan, Juan, Yin, Mengying, Zhong, Mengru, Zhang, Hongyan, Huang, Xiaohuan, Zhang, Yonghui. (1403). 'Naringin alleviates gefitinib-induced hepatotoxicity through anti-oxidation, inhibition of apoptosis, and autophagy', , 27(10), pp. 1309-1316. doi: 10.22038/ijbms.2024.76852.16623
Liu, Dan, Zhen, Changlin, He, Xiuzhen, chen, wansong, Pan, Juan, Yin, Mengying, Zhong, Mengru, Zhang, Hongyan, Huang, Xiaohuan, Zhang, Yonghui. Naringin alleviates gefitinib-induced hepatotoxicity through anti-oxidation, inhibition of apoptosis, and autophagy. , 1403; 27(10): 1309-1316. doi: 10.22038/ijbms.2024.76852.16623

Naringin alleviates gefitinib-induced hepatotoxicity through anti-oxidation, inhibition of apoptosis, and autophagy

Iranian Journal of Basic Medical Sciences
مقاله 11، دوره 27، شماره 10، دی 2024، صفحه 1309-1316    اصل مقاله (1.18 M)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22038/ijbms.2024.76852.16623
نویسندگان
Dan Liu؛ Changlin Zhen؛ Xiuzhen He؛ wansong chen؛ Juan Pan؛ Mengying Yin؛ Mengru Zhong؛ Hongyan Zhang؛ Xiaohuan Huang* ؛ Yonghui Zhang*
Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, Department of Basic Medicine, Chongqing Three Gorges Medical College, Chongqing 404120, China
چکیده
Objective(s): Gefitinib (GEF) is a targeted medicine used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC). However, GEF’s hepatotoxicity limits its clinical use. This study aims to investigate the protective effect of naringin (NG) against GEF-induced hepatotoxicity. 
Materials and Methods: Fifty female ICR mice were randomly divided into 5 groups: Control, GEF (200 mg/kg), NG (50 mg/kg) + GEF (200 mg/kg), NG (100 mg/kg) +GEF (200 mg/kg), NG (200 mg/kg) +GEF (200 mg/kg). After 4 weeks of continuous administration, the mice were euthanized. The blood and liver tissue samples were collected. 
Results: The results indicated that the GEF group showed increased liver index, liver enzyme activities, and decreased glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) activities. Some hepatocytes showed hydropic degeneration and focal necrosis. Cell apoptosis, Cleaved-caspase3, and Poly (ADP-ribose) polymerase 1 (PARP1) increased. Transmission electron microscopy revealed the presence of numerous autophagic lysosomes or autophagosomes around the cell nucleus. Compared to the GEF group, NG can reverse these changes. 
Conclusion: In summary, NG alleviates GEF-induced hepatotoxicity by anti-oxidation, inhibiting cell apoptosis, and autophagy. Therefore, this study suggests the use of NG to mitigate GEF’s toxicity to the liver.
کلیدواژه‌ها
Apoptosis؛ Autophagy؛ Gefitinib؛ Hepatotoxicity؛ Naringin
مراجع
آمار
تعداد مشاهده مقاله: 992
تعداد دریافت فایل اصل مقاله: 849